Barry Zorman
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer-related molecular mechanisms research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Pavel Sumazin (12 shared papers)Dolores H Lopez-Terrada (2 shared papers)Stephen Frederick Sarabia (2 shared papers)Lisa R. Treviño (1 shared paper)Patrick Thompson (1 shared paper)Milton J. Finegold (1 shared paper)Toni‐Ann Mistretta (1 shared paper)David A. Wheeler (1 shared paper)
- Journals
- Journal of Hepatology (3 papers)Nature Communications (3 papers)F1000Research (2 papers)Experimental Hematology (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Barry Zorman
24 papers receiving 920 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 298
- Hepatology 105
- Molecular Biology 485
- Virology 20
- Oncology 104
Countries citing papers authored by Barry Zorman
This map shows the geographic impact of Barry Zorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Zorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Zorman more than expected).
Fields of papers citing papers by Barry Zorman
This network shows the impact of papers produced by Barry Zorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Zorman. The network helps show where Barry Zorman may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry Zorman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 199 | |
| 2 | 2016 | 175 | |
| 3 | 2015 | 127 | |
| 4 | 2020 | 70 | |
| 5 | 2016 | 59 | |
| 6 | 2022 | 50 | |
| 7 | 2021 | 40 | |
| 8 | 2017 | 38 | |
| 9 | 2022 | 38 | |
| 10 | 2017 | 28 | |
| 11 | 2024 | 20 | |
| 12 | 2019 | 17 | |
| 13 | 2021 | 14 | |
| 14 | 2019 | 11 | |
| 15 | 2024 | 10 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 5 | |
| 18 | 2011 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2022 | 3 |
About Barry Zorman
Barry Zorman is a scholar working on Cancer Research, Hepatology, Hematology, Molecular Biology and Genetics, having authored 25 papers that have together received 927 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), CRISPR and Genetic Engineering (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Neuroblastoma Research and Treatments (2 papers), Cancer-related molecular mechanisms research (2 papers), Acute Myeloid Leukemia Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (298 citations), Hepatology (105 citations), Molecular Biology (485 citations), Virology (20 citations) and Oncology (104 citations). Barry Zorman has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Pavel Sumazin, Dolores H Lopez-Terrada, Stephen Frederick Sarabia, Lisa R. Treviño, Patrick Thompson, Milton J. Finegold, Toni‐Ann Mistretta, David A. Wheeler, Oliver A. Hampton and Andras Attila Heczey. Their work appears in journals such as Journal of Hepatology, Nature Communications, F1000Research, Experimental Hematology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.